Revised criteria on drug revaluation announced to be legislated

The KFDA announced to legislate "Revised bill for drug revaluation standard" on Nov. 12 for the purpose of supplementing problems and shortcomings as resulted from revaluation and examination of the product on subject having performed since 1999.

The revised drug revaluation provision may readjust number of case reports and consolidate items depending on each characteristic of products with...